Showing results (631-640 of 1,772) with videos related to
Sort By:
Pageof 178
Trends in Cardiovascular Medicine|November 30, 2002
The ABCA1 transporter and ApoA-I: obligate or facultative partners?Didier Marguet, Giovanna ChiminiTrends in Cardiovascular Medicine|November 30, 2002
Identification and regulation of protein components of the apolipoprotein B mRNA editing enzyme. A complex eventShrikant Anant, Nicholas O DavidsonTrends in Cardiovascular Medicine|October 13, 2001
Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistanceK Adeli, C Taghibiglou, S C Van Iderstine, et al.Trends in Cardiovascular Medicine|October 13, 2001
Matrix metalloproteinase inhibition and the prevention of heart failureR T LeeTrends in Cardiovascular Medicine|October 13, 2001
Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathyB C Knollmann, J D PotterTrends in Cardiovascular Medicine|November 1, 2001
Mechanisms for oxidizing low-density lipoprotein. Insights from patterns of oxidation products in the artery wall and from mouse models of atherosclerosisJ P Gaut, J W HeineckeTrends in Cardiovascular Medicine|November 1, 2001
Lipid peroxidation in mouse models of atherosclerosisD PraticòTrends in Cardiovascular Medicine|November 1, 2001
Oxidative DNA damage and cardiovascular diseaseS H Lee, I A BlairTrends in Cardiovascular Medicine|April 3, 2001
DGAT and triglyceride synthesis: a new target for obesity treatment?H C Chen, R V FareseTrends in Cardiovascular Medicine|April 3, 2001
Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular diseaseS A Douglas, E H OhlsteinPageof 178